Violeta Yu

Head of Discovery Biology US
Violeta Yu

Violeta leads US Discovery Biology and Neurological Disease Biology at Dewpoint. Violeta is a molecular pharmacologist who is passionate about improving the lives of patients. Violeta has ~25 years of drug discovery experience using innovative strategies – including condensate-targeted drug discovery, to screen, study, and progress potential therapies in the areas of Neuroscience, Oncology, Inflammation, and Metabolic Disorders.

She has successfully advanced multiple projects from discovery, screen, hit-to-lead, to clinical candidate, and authored over 30 peer-reviewed publications. She has worked on a diverse set of targets spanning ion channels (voltage and ligand gated), enzymes (including but not limited to kinases, histone modifying, nucleic acid modifying), and receptors. She is an effective team leader and engaged staff manager. Before joining Dewpoint, Violeta held multiple roles at Amgen, with expanded scope and responsibilities, leading to her managing the ALS Neuroscience staff and being responsible for creating and running all ALS projects. Violeta started her drug discovery career as a Biologist at Merck Frosst and was part of the research team (Donald Nicholson’s lab) that discovered caspase-3 and its central role in apoptosis.

Violeta was educated in Canada at the University of Waterloo and the University of Toronto. Outside of work, Violeta cherishes time with family and volunteering in her community.

Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
© 2019-2024 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science